Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0f9a1890fbbe4871e2bba0a9dcb5103 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-04 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D221-18 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D221-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-08 |
filingDate |
2016-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbdc266c8d072293690fbb4af8ee7110 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bd7fcf004836648d0c896d9d074393c |
publicationDate |
2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-10689324-B2 |
titleOfInvention |
Metabolism resistant fenfluramine analogs and methods of using the same |
abstract |
Metabolism-resistant fenfluramine analogs are provided. The subject fenfluramine analogs find use in the treatment of a variety of diseases. For example, methods of treating epilepsy by administering a fenfluramine analog to a subject in need thereof are provided. Also provided are methods of suppressing appetite in a subject in need thereof. Pharmaceutical compositions for use in practicing the subject methods are also provided. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406606-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11786487-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11759440-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11673852-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11325882-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11612574-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11571397-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11458111-B2 |
priorityDate |
2015-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |